Published price vs quote-only
Directmeds vs SnagRx: Which One Publishes Its Price? (2026)
Directmeds or SnagRx? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.8 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Directmeds and SnagRx usually comes down to one difference that neither homepage puts in its headline.
One of these programs can be evaluated before you start it and one cannot. SnagRx lists Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan; with Directmeds, standard post-promotional pricing is not disclosed upfront.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Easier to price in advance
- SnagRx — Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Directmeds — Neither publishes financing; both expect the full amount monthly.
Directmeds vs SnagRx: the specification
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| Directmeds | SnagRx | |
|---|---|---|
| Advertised price | 50% off the first month | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan |
| Rate after promotions | not published before intake | $99/mo |
| Pricing structure | Quoted only after intake | Flat rate at every dose |
| Medication | GLP-1 medication via licensed telehealth prescribing | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Quote only, after intake | Published upfront |
| Tirzepatide | Not published | $149/mo |
| Support model | No coaching program stated | No coaching program stated |
| Shipping | Nationwide shipping, no insurance required | Free next-day UPS or FedEx in temperature-controlled packaging |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 3,400 | 9,860 |
| eRxDoctor score | 7.8/10 | 7.5/10 |
What Directmeds and SnagRx actually cost over a year
The cheapest first month and the cheapest year are frequently different providers. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Directmeds | SnagRx | |
|---|---|---|
| First month | Not published | $99 |
| Months 2 onward | Not published | $99/mo |
| 6-month total | Not computable | $594 |
| 12-month total | Not computable | $1,188 |
| Best published plan | No multi-month discount published | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr |
A like-for-like annual total is not available for Directmeds: standard post-promotional pricing is not disclosed upfront. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
SnagRx publishes Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan before intake. That is the baseline condition for comparing two programs at all.
Directmeds inverts that: standard post-promotional pricing is not disclosed upfront. Personalization is a real justification, but the result is a quote delivered at the point you have already invested time in the process.
If you do go through Directmeds's intake, ask for the month-two price in writing before you pay for month one. That single question resolves most of the disclosure gap.
A closer look at Directmeds
Directmeds positions itself on a half-price first month and nationwide shipping with no insurance step. Directmeds is a licensed telehealth platform offering GLP-1 medications with a 50% first-month discount and nationwide shipping.
Practically: online intake, nationwide shipping, no insurance required, and a pricing model that is quoted only after intake.
Ongoing care is licensed telehealth prescribing, and the medication list runs to GLP-1 medication via licensed telehealth prescribing.
Directmeds pros
- 50% off first month for new patients
- Nationwide shipping, no insurance required
- Licensed telehealth prescribing model
Directmeds cons
- Standard (post-promo) pricing is not clearly disclosed upfront
Where it gives ground to SnagRx: a discount off an undisclosed price is not a price.
Inside the SnagRx program
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. Against Directmeds, that puts it in the position of the harder of the two to price in advance.
From signup to first shipment: 5-minute intake, clinician review typically within 5 hours and always within 24, then free next-day UPS or FedEx in temperature-controlled packaging. Billing follows a flat rate at every dose structure.
Support: 1:1 nursing staff plus a secure patient portal for refills and dose changes. The medications on offer are compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Full refund if the prescription is declined, plus a 6-month weight-loss guarantee (terms apply)
- Clinician review typically within 5 hours; next-day temperature-controlled shipping
- Price locked flat at every dose and at renewal — no re-pricing during titration
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
SnagRx cons
- Clinician network covers 48 states, not all 50
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
Set beside Directmeds, the thing to weigh: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Who each program is actually built for
Choose Directmeds if:
- what it leads on is worth paying for in your case: a half-price first month and nationwide shipping with no insurance step
- the level of clinical contact suits you: licensed telehealth prescribing
- you want to start on their timeline: online intake
- delivery works the way you want it to: nationwide shipping, no insurance required
Choose SnagRx if:
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- you want the full price in front of you before completing an intake
- you want tirzepatide available without changing provider later
- you want the price you sign up at to survive titration
Where each program concedes something
On price. Only SnagRx publishes a rate you can plan against (Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On clinical contact. Directmeds provides licensed telehealth prescribing. SnagRx provides 1:1 nursing staff plus a secure patient portal for refills and dose changes. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. Directmeds covers GLP-1 medication via licensed telehealth prescribing; SnagRx covers compounded semaglutide and compounded tirzepatide. Only SnagRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. Directmeds advertises online intake and nationwide shipping, no insurance required; SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging. Coverage differs too — nationwide against 48 states — which decides the question before price does if you are in a restricted state.
The medication, not the platform
Neither Directmeds nor SnagRx manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
In SURMOUNT-1, tirzepatide reached a mean body-weight reduction of about 21% at the 15 mg dose over 72 weeks, per NEJM, SURMOUNT-1.
Weight regain after withdrawal is the documented pattern: the STEP 1 extension recorded participants returning to close to their starting weight a year after stopping, per Diabetes, Obesity and Metabolism.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Directmeds vs SnagRx: common questions
How fast can I start with Directmeds compared with SnagRx?
Directmeds advertises online intake, with nationwide shipping, no insurance required. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Directmeds or SnagRx take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Can I switch from Directmeds to SnagRx later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge, and read the cancellation terms on any prepaid plan before you do.
Is Directmeds or SnagRx better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Directmeds has the stronger case; after month three, cost should take over.
Do Directmeds and SnagRx prescribe the same medication?
Both dispense compounded GLP-1 preparations. Directmeds lists GLP-1 medication via licensed telehealth prescribing and SnagRx lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
Does Directmeds or SnagRx offer tirzepatide?
SnagRx does, at $149/mo. Directmeds publishes GLP-1 medication via licensed telehealth prescribing only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Which has more patient reviews, Directmeds or SnagRx?
SnagRx, with 9,860 against 3,400. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Directmeds leads on a half-price first month and nationwide shipping with no insurance step; SnagRx leads on the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Directmeds vs MaximusPublished price vs quote-only
- Directmeds vs MeasuredPublished price vs quote-only
- SnagRx vs MaximusTirzepatide access
- SnagRx vs Elevate HealthHead to head
- Shed vs Ro.coPublished price vs quote-only
- Shed vs Sprout HealthPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Directmeds or SnagRx, and does not sell treatment. Read our ranking methodology.